Gufic Biosciences Limited has submitted a regulatory disclosure to both BSE Limited and National Stock Exchange of India Limited regarding an upcoming board meeting. The disclosure is made pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
A meeting of the Board of Directors is scheduled to be held on Saturday, November 14, 2026. The primary agenda includes considering and approving the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026.
The company also confirms the continuation of the trading window closure that was previously disclosed on September 28, 2026. This closure is in accordance with the Company's Code of Conduct for Prevention of Insider Trading, framed under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. The trading window restriction applies to all Designated Persons of the Company and their immediate relatives. The window will remain closed until 48 hours after the declaration of the financial results.